BRPI0417708A - derivados organofosfóricos dos indazóis e sua utilização como inibidores das proteìnas quinases - Google Patents
derivados organofosfóricos dos indazóis e sua utilização como inibidores das proteìnas quinasesInfo
- Publication number
- BRPI0417708A BRPI0417708A BRPI0417708-8A BRPI0417708A BRPI0417708A BR PI0417708 A BRPI0417708 A BR PI0417708A BR PI0417708 A BRPI0417708 A BR PI0417708A BR PI0417708 A BRPI0417708 A BR PI0417708A
- Authority
- BR
- Brazil
- Prior art keywords
- indazoles
- kinase inhibitors
- derivatives
- protein kinase
- organophosphoric
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/44—Amides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/65031—Five-membered rings having the nitrogen atoms in the positions 1 and 2
- C07F9/65038—Five-membered rings having the nitrogen atoms in the positions 1 and 2 condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Abstract
"DERIVADOS ORGANOFOSFóRICOS DOS INDAZóIS E SUA UTILIZAçãO COMO INIBIDORES DAS PROTEìNAS QUINASES". A presente invenção se refere notadamente aos novos compostos químicos, particularmente aos novos derivados organofosforados dos indazóis, as composições que os contêm, e sua utilização como medicamentos para tratar os cânceres.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0314778A FR2864084B1 (fr) | 2003-12-17 | 2003-12-17 | Nouveaux derives organophosphores des indazoles et leur utilisation comme medicaments |
PCT/FR2004/003225 WO2005058923A1 (fr) | 2003-12-17 | 2004-12-15 | Derives organophosphores des indazoles et leur utilisation comme inhibiteurs des proteines kinase |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0417708A true BRPI0417708A (pt) | 2007-03-20 |
Family
ID=34630228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0417708-8A BRPI0417708A (pt) | 2003-12-17 | 2004-12-15 | derivados organofosfóricos dos indazóis e sua utilização como inibidores das proteìnas quinases |
Country Status (17)
Country | Link |
---|---|
US (1) | US7491710B2 (pt) |
EP (1) | EP1732938B1 (pt) |
JP (1) | JP4630285B2 (pt) |
KR (1) | KR20060109942A (pt) |
CN (1) | CN1894264A (pt) |
AR (1) | AR046736A1 (pt) |
AT (1) | ATE430754T1 (pt) |
AU (1) | AU2004299299A1 (pt) |
BR (1) | BRPI0417708A (pt) |
CA (1) | CA2546903A1 (pt) |
DE (1) | DE602004021037D1 (pt) |
FR (1) | FR2864084B1 (pt) |
IL (1) | IL176233A0 (pt) |
MX (1) | MXPA06006832A (pt) |
TW (1) | TW200529828A (pt) |
UY (1) | UY28679A1 (pt) |
WO (1) | WO2005058923A1 (pt) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005061519A1 (en) * | 2003-12-19 | 2005-07-07 | Takeda San Diego, Inc. | Kinase inhibitors |
JP2007533753A (ja) * | 2004-04-23 | 2007-11-22 | タケダ サン ディエゴ インコーポレイテッド | インドール誘導体及びキナーゼ阻害剤としてのその使用 |
US7550598B2 (en) * | 2004-08-18 | 2009-06-23 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
EP1647549A1 (en) | 2004-10-14 | 2006-04-19 | Laboratoire Theramex | Indazoles, benzisoxazoles and benzisothiazoles as estrogenic agents |
US7713973B2 (en) * | 2004-10-15 | 2010-05-11 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
DE102004052725B4 (de) * | 2004-10-27 | 2007-07-12 | Technische Universität Chemnitz | Verfahren zur Herstellung substituierter Phosphane und nach dem Verfahren hergestellte substituierte Phosphane |
US7605272B2 (en) * | 2005-01-27 | 2009-10-20 | Kyowa Hakko Kirin Co., Ltd. | IGF-1R inhibitor |
US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
US20120329794A1 (en) | 2006-06-30 | 2012-12-27 | Kyowa Hakko Kirin Co., Ltd. | Ab1 KINASE INHIBITORS |
EP2036894A4 (en) | 2006-06-30 | 2011-01-12 | Kyowa Hakko Kirin Co Ltd | AURORA INHIBITOR |
JP2010505962A (ja) | 2006-10-09 | 2010-02-25 | 武田薬品工業株式会社 | キナーゼ阻害剤 |
EP2133095A4 (en) | 2007-03-05 | 2012-09-26 | Kyowa Hakko Kirin Co Ltd | PHARMACEUTICAL COMPOSITION |
CN101440092B (zh) * | 2008-12-25 | 2010-11-17 | 浙江大学 | 2-吲唑-4-氮杂吲哚-5-氨基衍生物及制备和应用 |
WO2011019651A1 (en) * | 2009-08-10 | 2011-02-17 | Epitherix, Llc | Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
CN102595899A (zh) * | 2009-08-10 | 2012-07-18 | 埃皮瑟瑞克斯有限公司 | 作为wnt/b-联蛋白信号传导途径抑制剂的吲唑及其治疗用途 |
WO2011084486A1 (en) | 2009-12-21 | 2011-07-14 | Epitherix, Llc | 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
RU2627693C2 (ru) | 2011-09-14 | 2017-08-10 | СЭМЬЮМЕД, ЭлЭлСи | ИНДАЗОЛ-3-КАРБОКСАМИДЫ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ СИГНАЛЬНОГО ПУТИ WNT/b-КАТЕНИНА |
PH12017500997A1 (en) | 2012-04-04 | 2018-02-19 | Samumed Llc | Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
BR112014024284B1 (pt) | 2012-05-04 | 2021-08-31 | Samumed, Llc | Compostos de 1h-pirazolo[3,4-b]piridinas, composição farmacêutica compreendendo ditos compostos e usos terapêuticos destes |
CA2897400A1 (en) | 2013-01-08 | 2014-07-17 | Samumed, Llc | 3-(benzoimidazol-2-yl)-indazole inhibitors of the wnt signaling pathway and therapeutic uses thereof |
WO2016040185A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof |
WO2016040184A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof |
WO2016040193A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof |
WO2016040188A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof |
WO2016040182A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine and therapeutic uses thereof |
WO2016040181A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof |
WO2016040180A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof |
WO2016040190A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof |
WO2017024025A1 (en) | 2015-08-03 | 2017-02-09 | Sunil Kumar Kc | 3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof |
WO2017023975A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof |
US10195185B2 (en) | 2015-08-03 | 2019-02-05 | Samumed, Llc | 3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
US10166218B2 (en) | 2015-08-03 | 2019-01-01 | Samumed, Llc | 3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof |
US10329309B2 (en) | 2015-08-03 | 2019-06-25 | Samumed, Llc | 3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
WO2017023988A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof |
WO2017023987A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
WO2017024003A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc | 3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof |
WO2017024010A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof |
US10226453B2 (en) | 2015-08-03 | 2019-03-12 | Samumed, Llc | 3-(1H-indol-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
US10285982B2 (en) | 2015-08-03 | 2019-05-14 | Samumed, Llc | 3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof |
WO2017024021A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc | 3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof |
WO2017023984A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof |
WO2017023986A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc | 3-(1h-indol-2-yl)-1h-indazoles and therapeutic uses thereof |
US10285983B2 (en) | 2015-08-03 | 2019-05-14 | Samumed, Llc | 3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-B] pyridines and therapeutic uses thereof |
US10206909B2 (en) | 2015-08-03 | 2019-02-19 | Samumed, Llc | 3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
WO2017023989A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof |
CA3004506A1 (en) | 2015-11-06 | 2017-05-11 | Samumed, Llc | Use of n-(5-(3-(7-(3- fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide in the treatment of osteoarthritis |
JP6659445B2 (ja) * | 2016-04-28 | 2020-03-04 | 株式会社トクヤマ | 脱ベンジル化方法 |
SG10201912248RA (en) | 2016-06-01 | 2020-02-27 | Samumed Llc | Process for preparing n-(5-(3-(7-(3-fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide |
RU2770613C2 (ru) | 2016-10-21 | 2022-04-19 | СЭМЬЮМЕД, ЭлЭлСи | Способы применения индазол-3-карбоксамидов и их применение в качестве ингибиторов сигнального пути wnt/в-катенина |
KR102558716B1 (ko) | 2016-11-07 | 2023-07-21 | 사뮤메드, 엘엘씨 | 단일-투여량, 즉시-사용가능한 주사용 제제 |
WO2021088859A1 (zh) * | 2019-11-06 | 2021-05-14 | 暨南大学 | 吲唑类化合物及其药用组合物和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0630367B1 (en) * | 1992-03-09 | 2000-07-05 | Zeneca Limited | Novel arylindazoles and their use as herbicides |
JPH09281630A (ja) * | 1996-04-12 | 1997-10-31 | Konica Corp | ハロゲン化銀写真感光材料 |
US7217722B2 (en) * | 2000-02-01 | 2007-05-15 | Kirin Beer Kabushiki Kaisha | Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
TW200306819A (en) * | 2002-01-25 | 2003-12-01 | Vertex Pharma | Indazole compounds useful as protein kinase inhibitors |
FR2836914B1 (fr) * | 2002-03-11 | 2008-03-14 | Aventis Pharma Sa | Indazoles substitues, compositions les contenant, procede de fabrication et utilisation |
-
2003
- 2003-12-17 FR FR0314778A patent/FR2864084B1/fr not_active Expired - Fee Related
-
2004
- 2004-11-30 AR ARP040104454A patent/AR046736A1/es unknown
- 2004-12-15 KR KR1020067012037A patent/KR20060109942A/ko not_active Application Discontinuation
- 2004-12-15 DE DE602004021037T patent/DE602004021037D1/de active Active
- 2004-12-15 JP JP2006544494A patent/JP4630285B2/ja not_active Expired - Fee Related
- 2004-12-15 AT AT04805706T patent/ATE430754T1/de not_active IP Right Cessation
- 2004-12-15 MX MXPA06006832A patent/MXPA06006832A/es active IP Right Grant
- 2004-12-15 WO PCT/FR2004/003225 patent/WO2005058923A1/fr not_active Application Discontinuation
- 2004-12-15 AU AU2004299299A patent/AU2004299299A1/en not_active Abandoned
- 2004-12-15 BR BRPI0417708-8A patent/BRPI0417708A/pt not_active IP Right Cessation
- 2004-12-15 CA CA002546903A patent/CA2546903A1/fr not_active Abandoned
- 2004-12-15 CN CNA2004800376955A patent/CN1894264A/zh active Pending
- 2004-12-15 EP EP04805706A patent/EP1732938B1/fr active Active
- 2004-12-16 TW TW093139037A patent/TW200529828A/zh unknown
- 2004-12-17 US US11/016,595 patent/US7491710B2/en not_active Expired - Fee Related
- 2004-12-17 UY UY28679A patent/UY28679A1/es unknown
-
2006
- 2006-06-11 IL IL176233A patent/IL176233A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2546903A1 (fr) | 2005-06-30 |
FR2864084A1 (fr) | 2005-06-24 |
FR2864084B1 (fr) | 2006-02-10 |
US20050137171A1 (en) | 2005-06-23 |
JP2007514721A (ja) | 2007-06-07 |
AR046736A1 (es) | 2005-12-21 |
EP1732938B1 (fr) | 2009-05-06 |
EP1732938A1 (fr) | 2006-12-20 |
MXPA06006832A (es) | 2006-09-04 |
IL176233A0 (en) | 2006-10-05 |
US7491710B2 (en) | 2009-02-17 |
DE602004021037D1 (de) | 2009-06-18 |
ATE430754T1 (de) | 2009-05-15 |
KR20060109942A (ko) | 2006-10-23 |
UY28679A1 (es) | 2005-08-31 |
WO2005058923A1 (fr) | 2005-06-30 |
TW200529828A (en) | 2005-09-16 |
AU2004299299A1 (en) | 2005-06-30 |
JP4630285B2 (ja) | 2011-02-09 |
CN1894264A (zh) | 2007-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0417708A (pt) | derivados organofosfóricos dos indazóis e sua utilização como inibidores das proteìnas quinases | |
BRPI0517435A (pt) | triazóis úteis como inibidores de proteìna cinase | |
BRPI0515081A (pt) | derivados de fenilaminopirimidina como inibidores de bcr-abl cinase | |
SE0301700D0 (sv) | Novel compounds | |
BRPI0407454A (pt) | Pirazóis e métodos de preparar e usar os mesmos | |
EA200802213A1 (ru) | Способы лечения заболеваний крови | |
DK1853602T3 (da) | Kemiske forbindelser | |
DK1853588T3 (da) | Kemiske forbindelser | |
BRPI0411721A (pt) | derivados de tiazolilpiperidina como inibidores de mtp | |
HRP20050533A2 (en) | Aminoindazole derivatives and use thereof as kinase inhibitors | |
NO20082089L (no) | Fosfatidylinositol 3-kinaseinhibitorer og deres anvendelse | |
ATE408601T1 (de) | Fredericamycin-derivate | |
CR10072A (es) | Derivados de pirimidinil-aril-urea que son inhibidores de fgf | |
BRPI0606379A2 (pt) | triazolftalazinas | |
BRPI0312464B8 (pt) | compostos inibidores de tirosina quinases, composições farmacêuticas compreendendo os mesmos, processos para fabricação e usos dos mesmos | |
DK1519724T3 (da) | Fredericamycin-derivater som lægemidler til behandling af tumorer | |
UY29886A1 (es) | Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones | |
SE0202539D0 (sv) | Compounds | |
ATE527253T1 (de) | Pyrimidin-substituierte benzimidazolderivate als proteinkinasehemmer | |
CL2008000020A1 (es) | Compuestos derivados de 2,4-dianilinopirimidinas sustituidas, inhibidores de proteinas cinasas; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades inflamatorias, diabetes y tumores malignos. | |
BRPI0418031A (pt) | inibidores de quinase fosfonato-substituìdos | |
BRPI0517737A (pt) | inibidores de quinase | |
TW200736189A (en) | Indene derivatives, their preparation and use as medicaments | |
CR9528A (es) | Inhibitors of microsomal triglyceride transfer protein and apo-b secretion | |
BRPI0512986A (pt) | novos derivados de hidantoìna |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |